PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

To the naysayer's...I say 2018 should no doubt be the year PharmaCyte proves that its Cell-in-a-Box encapsulation technology can successfully be used in therapies to fight disease. And with continued faith and hope, we'll all- patients and investors alike, soon be blessed with its success.

CiaB's technology looks to be coming full circle. As you know, this entire project began with its inception, and now..it seems to be ending with it as well. Meaning, that although there is the potential of PharmaCyte conducting its first FDA regulated PC clinical trial....it would certainly not be possible without its Cell-in-a-Box technology.

Yes, years of clinical and laboratory work has gone into researching and experimenting with PC, diabetes, ascites, and other diseases, but what is the driver?...that common denominator?...the one thing that matters most to PharmaCyte's success? Cell-in-a-Box

And with all the FDA requirements for the IND and to begin the clinical trial, guess which task, assigned to Austrianova, is basically the last one to be completed? Cell-in-a-Box

Its completion is potentially upon us, as is the trial. And of course, if the trial comes...you know what happens next!

A partner announcement! Kabooooom!

...or maybe even a buyout announcement! Kabooooom!

We're almost there. :) :) :)

Go PharmaCyte!!!!